A case-control study of prevalence of anemia among patients with type 2 diabetes
- PMID: 27142617
- PMCID: PMC4855820
- DOI: 10.1186/s13256-016-0889-4
A case-control study of prevalence of anemia among patients with type 2 diabetes
Abstract
Background: Anemia is defined as a reduction in the hemoglobin concentration of blood, which consequently reduces the oxygen-carrying capacity of red blood cells such that they are unable to meet the body's physiological needs. Several reports have indicated that anemia mostly occurs in patients with diabetes with renal insufficiency while limited studies have reported the incidence of anemia in people with diabetes prior to evidence of renal impairment. Other studies have also identified anemia as a risk factor for the need for renal replacement therapy in diabetes. Understanding the pathogenesis of anemia associated with diabetes may lead to the development of interventions to optimize outcomes in these patients. The aim of this study was therefore to determine the prevalence of anemia among patients with type 2 diabetes.
Methods: A total of 100 (50 with type 2 diabetes and 50 controls) participants were recruited for our study. Participants' blood samples were analyzed for fasting blood glucose, full blood count and renal function tests among others. The prevalence of anemia was then determined statistically.
Results: A high incidence of anemia was observed in the cases. Of the patients with diabetes, 84.8% had a hemoglobin concentration that was significantly less (males 11.16±1.83 and females 10.41±1.49) than the controls (males 14.25±1.78 and females 12.53±1.14). Renal insufficiency determined by serum creatinine level of >1.5 mg/dL, estimated glomerular filtration rate <60 ml/minute/1.73 m2, and erythropoietin levels was also observed to be high in the cases (54.0%; with mean creatinine concentration of 3.43±1.73 and erythropoietin 6.35±1.28 mIU/mL). A significantly increased fasting blood glucose, urea, sodium, potassium, and calcium ions were observed in the cases (7.99±1.30, 5.19±1.99, 140.90±6.98, 4.86±0.53 and 1.47±0.31 respectively) as compared to the controls (4.66±0.54, 3.56±2.11, 135.51±6.84, 4.40±0.58 and 1.28±0.26 respectively). Finally, a significant association between hemoglobin concentration and fasting blood glucose was also observed in the cases.
Conclusions: The findings suggest that a high incidence of anemia is likely to occur in patients with poorly controlled diabetes and in patients with diabetes and renal insufficiency.
Keywords: Anemia; Diabetes; Hemoglobin concentration; Renal insufficiency.
Figures
Similar articles
-
Prevalence and Classification of Anemia among Renal Failure Patients of Al Majmaah and Al Zulfi Hospitals, Riyadh, Saudi Arabia.Clin Lab. 2025 Apr 1;71(4). doi: 10.7754/Clin.Lab.2024.241046. Clin Lab. 2025. PMID: 40209774
-
Anaemia and type 2 diabetes: implications from a retrospectively studied primary care case series.Hong Kong Med J. 2013 Jun;19(3):214-21. doi: 10.12809/hkmj133814. Epub 2013 Apr 3. Hong Kong Med J. 2013. PMID: 23568938
-
Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study.Arch Intern Med. 2005 Oct 24;165(19):2222-7. doi: 10.1001/archinte.165.19.2222. Arch Intern Med. 2005. PMID: 16246987 Clinical Trial.
-
Competing Effects of Renin Angiotensin System Blockade and Sodium-Glucose Cotransporter-2 Inhibitors on Erythropoietin Secretion in Diabetes.Am J Nephrol. 2020;51(5):349-356. doi: 10.1159/000507272. Epub 2020 Apr 2. Am J Nephrol. 2020. PMID: 32241009 Review.
-
Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.J Am Med Dir Assoc. 2006 Nov;7(9 Suppl):S7-S12; quiz S17-21. doi: 10.1016/j.jamda.2006.09.005. J Am Med Dir Assoc. 2006. PMID: 17098634 Review.
Cited by
-
Determinants of Anemia Among Patients with Chronic Kidney Disease: A Systematic Review of Empirical Evidence.J Multidiscip Healthc. 2025 Jun 28;18:3765-3780. doi: 10.2147/JMDH.S535423. eCollection 2025. J Multidiscip Healthc. 2025. PMID: 40605846 Free PMC article. Review.
-
Assessment of Erythrocyte Osmotic Fragility and Its Determinants, and Comparison of Hematological Indices Among Type 2 Diabetes Mellitus Patients on Follow-Up at Jimma Medical Center, Southwest Ethiopia.J Blood Med. 2024 Jan 22;15:9-19. doi: 10.2147/JBM.S445620. eCollection 2024. J Blood Med. 2024. PMID: 38283856 Free PMC article.
-
Diabetes and Anaemia: A Myth or Reality.J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2279-S2281. doi: 10.4103/jpbs.jpbs_213_24. Epub 2024 Jun 7. J Pharm Bioallied Sci. 2024. PMID: 39346437 Free PMC article.
-
Type 2 diabetes and in-hospital complications after revision of total hip and knee arthroplasty.PLoS One. 2017 Aug 24;12(8):e0183796. doi: 10.1371/journal.pone.0183796. eCollection 2017. PLoS One. 2017. PMID: 28837689 Free PMC article.
-
Anemia and Its Associated Factors Among Type 2 Diabetes Mellitus Patients Attending Debre Berhan Referral Hospital, North-East Ethiopia: A Cross-Sectional Study.J Blood Med. 2020 Feb 11;11:47-58. doi: 10.2147/JBM.S243234. eCollection 2020. J Blood Med. 2020. PMID: 32104127 Free PMC article.
References
-
- Hoffbrand AV, Moss PAH, Pettit JE. Erythropoiesis and general aspects of anaemia. Essential Haematology. Fifth ed. UK: Blackwell Publishing; 2006. pp. 18–20.
-
- Ciesla B. Red blood cell production, function, and relevant red cell morphology. Haematology in practice. Philadelphia: F. A. Davis Company; 2007. pp. 37–46.
-
- Dallman PR. Iron. In: Brown M, editor. Present knowledge in nutrition. Washington: Nutrition Foundation; 1990. pp. 241–50.
-
- World Health Organization . The world health report: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002. - PubMed
-
- World Health Organization . Worldwide prevalence of anaemia 1993–2005. WHO Global Database on Anaemia. Geneva: WHO Press; 2008. pp. 7–8.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical